25 XP   0   0   10

Axonics Modulation Technologies Inc
Buy, Hold or Sell?

Let's analyse Axonics together

PenkeI guess you are interested in Axonics Modulation Technologies Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Axonics Modulation Technologies Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Axonics Modulation Technologies Inc

I send you an email if I find something interesting about Axonics Modulation Technologies Inc.

Quick analysis of Axonics (30 sec.)










What can you expect buying and holding a share of Axonics? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$12.50
Expected worth in 1 year
$13.82
How sure are you?
46.2%

+ What do you gain per year?

Total Gains per Share
$1.32
Return On Investment
2.0%

For what price can you sell your share?

Current Price per Share
$66.47
Expected price per share
$55.55 - $69.67
How sure are you?
50%

1. Valuation of Axonics (5 min.)




Live pricePrice per Share (EOD)

$66.47

Intrinsic Value Per Share

$28.07 - $33.98

Total Value Per Share

$40.57 - $46.48

2. Growth of Axonics (5 min.)




Is Axonics growing?

Current yearPrevious yearGrowGrow %
How rich?$637.5m$505.2m$104.9m17.2%

How much money is Axonics making?

Current yearPrevious yearGrowGrow %
Making money-$1.5m-$14.9m$13.4m880.6%
Net Profit Margin-8.8%-25.1%--

How much money comes from the company's main activities?

3. Financial Health of Axonics (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#49 / 334

Most Revenue
#88 / 334

Most Profit
#156 / 334

Most Efficient
#149 / 334

What can you expect buying and holding a share of Axonics? (5 min.)

Welcome investor! Axonics's management wants to use your money to grow the business. In return you get a share of Axonics.

What can you expect buying and holding a share of Axonics?

First you should know what it really means to hold a share of Axonics. And how you can make/lose money.

Speculation

The Price per Share of Axonics is $66.47. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Axonics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Axonics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $12.50. Based on the TTM, the Book Value Change Per Share is $0.33 per quarter. Based on the YOY, the Book Value Change Per Share is $0.43 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Axonics.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.130.2%0.030.0%-0.29-0.4%-0.26-0.4%-0.23-0.4%
Usd Book Value Change Per Share0.530.8%0.330.5%0.430.6%0.480.7%0.480.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.530.8%0.330.5%0.430.6%0.480.7%0.480.7%
Usd Price Per Share62.23-55.85-63.06-50.05-39.08-
Price to Earnings Ratio120.70-97.87-268.70-52.66-39.74-
Price-to-Total Gains Ratio117.80-12.68--23.41--99.12--94.22-
Price to Book Ratio4.98-4.67-6.41-7.70-6.13-
Price-to-Total Gains Ratio117.80-12.68--23.41--99.12--94.22-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share66.47
Number of shares15
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.330.48
Usd Total Gains Per Share0.330.48
Gains per Quarter (15 shares)4.967.27
Gains per Year (15 shares)19.8329.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10201002919
20403005848
30595008777
4079700116106
5099900145135
601191100174164
701391300204193
801591500233222
901781700262251
1001981900291280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%4.08.00.033.3%4.016.00.020.0%4.022.00.015.4%4.022.00.015.4%
Book Value Change Per Share3.01.00.075.0%7.05.00.058.3%9.011.00.045.0%12.014.00.046.2%12.014.00.046.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.026.00.0%0.00.026.00.0%
Total Gains per Share3.01.00.075.0%7.05.00.058.3%9.011.00.045.0%12.014.00.046.2%12.014.00.046.2%

Fundamentals of Axonics

About Axonics Modulation Technologies Inc

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

Fundamental data was last updated by Penke on 2024-04-11 01:39:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Axonics Modulation Technologies Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Axonics earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • A Net Profit Margin of 6.0% means that $0.06 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Axonics Modulation Technologies Inc:

  • The MRQ is 6.0%. The company is making a profit. +1
  • The TTM is -8.8%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ6.0%TTM-8.8%+14.8%
TTM-8.8%YOY-25.1%+16.2%
TTM-8.8%5Y-260.2%+251.4%
5Y-260.2%10Y-168,229.7%+167,969.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0%-12.4%+18.4%
TTM-8.8%-20.4%+11.6%
YOY-25.1%-14.8%-10.3%
5Y-260.2%-21.3%-238.9%
10Y-168,229.7%-25.0%-168,204.7%
1.1.2. Return on Assets

Shows how efficient Axonics is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • 0.9% Return on Assets means that Axonics generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Axonics Modulation Technologies Inc:

  • The MRQ is 0.9%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.9%TTM-0.3%+1.2%
TTM-0.3%YOY-2.7%+2.5%
TTM-0.3%5Y-4.9%+4.6%
5Y-4.9%10Y-7.2%+2.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9%-4.1%+5.0%
TTM-0.3%-4.7%+4.4%
YOY-2.7%-4.8%+2.1%
5Y-4.9%-4.0%-0.9%
10Y-7.2%-5.2%-2.0%
1.1.3. Return on Equity

Shows how efficient Axonics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • 1.0% Return on Equity means Axonics generated $0.01 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Axonics Modulation Technologies Inc:

  • The MRQ is 1.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.0%TTM0.0%+1.0%
TTM0.0%YOY-3.2%+3.2%
TTM0.0%5Y-6.0%+6.0%
5Y-6.0%10Y-5.8%-0.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0%-4.2%+5.2%
TTM0.0%-5.8%+5.8%
YOY-3.2%-5.7%+2.5%
5Y-6.0%-6.3%+0.3%
10Y-5.8%-7.1%+1.3%

1.2. Operating Efficiency of Axonics Modulation Technologies Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Axonics is operating .

  • Measures how much profit Axonics makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • An Operating Margin of 4.2% means the company generated $0.04  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Axonics Modulation Technologies Inc:

  • The MRQ is 4.2%. The company is operating less efficient.
  • The TTM is 19.6%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ4.2%TTM19.6%-15.4%
TTM19.6%YOY-18.2%+37.8%
TTM19.6%5Y-246.7%+266.3%
5Y-246.7%10Y-164,560.7%+164,314.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2%-24.3%+28.5%
TTM19.6%-16.4%+36.0%
YOY-18.2%-13.7%-4.5%
5Y-246.7%-19.9%-226.8%
10Y-164,560.7%-24.5%-164,536.2%
1.2.2. Operating Ratio

Measures how efficient Axonics is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.96 means that the operating costs are $0.96 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Axonics Modulation Technologies Inc:

  • The MRQ is 0.958. The company is less efficient in keeping operating costs low.
  • The TTM is 1.765. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.958TTM1.765-0.807
TTM1.765YOY1.188+0.577
TTM1.7655Y3.738-1.973
5Y3.73810Y1,685.193-1,681.455
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9581.442-0.484
TTM1.7651.439+0.326
YOY1.1881.431-0.243
5Y3.7381.436+2.302
10Y1,685.1931.374+1,683.819

1.3. Liquidity of Axonics Modulation Technologies Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Axonics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 10.73 means the company has $10.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Axonics Modulation Technologies Inc:

  • The MRQ is 10.726. The company is very able to pay all its short-term debts. +2
  • The TTM is 11.343. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.726TTM11.343-0.617
TTM11.343YOY9.262+2.082
TTM11.3435Y11.329+0.015
5Y11.32910Y11.426-0.097
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ10.7262.726+8.000
TTM11.3432.732+8.611
YOY9.2623.510+5.752
5Y11.3293.617+7.712
10Y11.4263.499+7.927
1.3.2. Quick Ratio

Measures if Axonics is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • A Quick Ratio of 14.02 means the company can pay off $14.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Axonics Modulation Technologies Inc:

  • The MRQ is 14.020. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 14.003. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ14.020TTM14.003+0.017
TTM14.003YOY8.559+5.444
TTM14.0035Y11.415+2.588
5Y11.41510Y11.896-0.481
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ14.0201.491+12.529
TTM14.0031.633+12.370
YOY8.5592.113+6.446
5Y11.4152.295+9.120
10Y11.8962.255+9.641

1.4. Solvency of Axonics Modulation Technologies Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Axonics assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Axonics to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.11 means that Axonics assets are financed with 11.4% credit (debt) and the remaining percentage (100% - 11.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Axonics Modulation Technologies Inc:

  • The MRQ is 0.114. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.094. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.114TTM0.094+0.021
TTM0.094YOY0.133-0.039
TTM0.0945Y0.151-0.057
5Y0.15110Y0.394-0.243
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1140.389-0.275
TTM0.0940.386-0.292
YOY0.1330.335-0.202
5Y0.1510.442-0.291
10Y0.3940.461-0.067
1.4.2. Debt to Equity Ratio

Measures if Axonics is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Axonics to the Medical Devices industry mean.
  • A Debt to Equity ratio of 12.9% means that company has $0.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Axonics Modulation Technologies Inc:

  • The MRQ is 0.129. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.091. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.129TTM0.091+0.038
TTM0.091YOY0.154-0.062
TTM0.0915Y0.180-0.089
5Y0.18010Y0.166+0.014
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1290.551-0.422
TTM0.0910.554-0.463
YOY0.1540.479-0.325
5Y0.1800.622-0.442
10Y0.1660.674-0.508

2. Market Valuation of Axonics Modulation Technologies Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Axonics generates.

  • Above 15 is considered overpriced but always compare Axonics to the Medical Devices industry mean.
  • A PE ratio of 120.70 means the investor is paying $120.70 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Axonics Modulation Technologies Inc:

  • The EOD is 128.924. Based on the earnings, the company is expensive. -2
  • The MRQ is 120.701. Based on the earnings, the company is expensive. -2
  • The TTM is 97.870. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD128.924MRQ120.701+8.224
MRQ120.701TTM97.870+22.830
TTM97.870YOY268.697-170.826
TTM97.8705Y52.658+45.212
5Y52.65810Y39.740+12.919
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD128.924-1.077+130.001
MRQ120.701-1.704+122.405
TTM97.870-2.081+99.951
YOY268.697-2.978+271.675
5Y52.658-2.379+55.037
10Y39.740-1.726+41.466
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Axonics Modulation Technologies Inc:

  • The EOD is 196.056. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 183.550. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -56.761. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD196.056MRQ183.550+12.506
MRQ183.550TTM-56.761+240.311
TTM-56.761YOY-43.527-13.234
TTM-56.7615Y-49.570-7.191
5Y-49.57010Y-38.909-10.661
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD196.056-0.932+196.988
MRQ183.550-1.578+185.128
TTM-56.761-2.973-53.788
YOY-43.527-6.318-37.209
5Y-49.570-5.307-44.263
10Y-38.909-5.171-33.738
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Axonics is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 4.98 means the investor is paying $4.98 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Axonics Modulation Technologies Inc:

  • The EOD is 5.317. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.978. Based on the equity, the company is fair priced.
  • The TTM is 4.668. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.317MRQ4.978+0.339
MRQ4.978TTM4.668+0.310
TTM4.668YOY6.406-1.738
TTM4.6685Y7.704-3.036
5Y7.70410Y6.133+1.571
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD5.3171.876+3.441
MRQ4.9782.372+2.606
TTM4.6682.434+2.234
YOY6.4063.217+3.189
5Y7.7043.893+3.811
10Y6.1334.245+1.888
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Axonics Modulation Technologies Inc.

3.1. Institutions holding Axonics Modulation Technologies Inc

Institutions are holding 102.091% of the shares of Axonics Modulation Technologies Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31FMR Inc10.63850.0259542600786756319.032
2023-12-31Vanguard Group Inc10.31470.00725260830-1484-0.0282
2023-12-31BlackRock Inc8.21480.006741898172757077.0439
2023-12-31Champlain Investment Partners, LLC3.75880.70741917133-96268-4.7814
2023-12-31Bellevue Group AG3.59421.7451833165-419686-18.6291
2023-12-31Amvescap Plc.3.57790.027182484618986211.6125
2023-12-31BAMCO Inc3.52520.2981797963-1768-0.0982
2023-12-31AXA SA3.07720.31491569466-158645-9.1803
2023-12-31Loomis, Sayles & Company LP2.55150.1241301360487263.8899
2023-12-31Hood River Capital Management LLC2.54552.22171298285-54815-4.0511
2023-12-31Mackenzie Investments2.45080.11731250005108720.8774
2023-12-31Goldman Sachs Group Inc2.43740.00691243140661876113.8684
2023-12-31Artisan Partners Limited Partnership2.39370.117122088958395891.6831
2023-12-31State Street Corporation2.36030.00361203858472864.0885
2023-12-31Geode Capital Management, LLC2.16040.00721101900603085.79
2023-12-31Credit Suisse First Boston (CSFB)1.92940.059984060-102312-9.4178
2023-12-31Dimensional Fund Advisors, Inc.1.80830.0168922295564186.5157
2023-09-30Citadel Advisors Llc1.47070.00975012634800686.5428
2023-12-31Wasatch Advisors Inc.1.38130.241570452150460.7214
2023-12-31Amundi1.34370.0213685325-14592-2.0848
Total 71.53436.077436484991+2306058+6.3%

3.2. Funds holding Axonics Modulation Technologies Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv3.11190.0071587163-4143-0.2604
2024-02-29Champlain Small Company Fund, LLC2.82292.11191439758-1900-0.1318
2024-02-29Vanguard Small Cap Index2.56060.06311305990121960.9427
2024-03-28iShares Russell 2000 ETF2.38780.1283121784861490.5075
2023-11-30Bellevue Healthcare Ord2.11056.85021076432-219495-16.9373
2023-12-31Baron Opp. Small Cap Growth Strategy1.96071.3456100000000
2023-12-31Baron Small Cap Retail1.96071.3474100000000
2024-01-31Canada Life US Small-Mid Cap Growth A1.78832.811391209700
2023-12-31Invesco OFI Small Cap Growth1.69131.39118626199756212.7523
2023-12-31Champlain Small Company Adv1.52931.982780000-55000-6.5868
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.46840.049974892512940.1731
2024-02-29Vanguard Small Cap Growth Index Inv1.43370.142473125993461.2946
2023-12-31Hood River Small-Cap Growth Instl1.29042.1888658143900.0137
2023-12-31Baron Discovery Strategy1.25092.779963798200
2023-12-31Baron Discovery Institutional1.25092.777863798200
2023-12-31Artisan Non-U.S. Small-Mid Growth Comp1.03490.731852781013512134.4092
2023-12-31Artisan International Small-Mid Investor1.03490.732552781013512134.4092
2024-01-31Fidelity Small Cap Index0.9870.137850342777341.5602
2023-12-31American Funds SMALLCAP World A0.95680.042248800000
2024-01-31Old Westbury Small & Mid Cap Strategies0.88230.414450000-105894-19.0493
Total 33.514228.03517093245+18181+0.1%

3.3. Insider Transactions

Insiders are holding 1.07% of the shares of Axonics Modulation Technologies Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-31John WoockSELL1589967.74
2024-01-31Karen NoblettSELL1128867.74
2024-01-31Kari Leigh KeeseSELL348967.74
2024-01-31Raymond W CohenSELL3516167.74
2024-01-08Karen NoblettSELL1599969
2023-12-28Karen NoblettSELL705163.28
2023-12-26Karen NoblettSELL94963
2023-09-29Danny L DearenSELL767556.87
2023-08-15Alfred J Ford JrSELL1476962.34
2023-07-28Alfred J Ford JrSELL150062.01
2023-05-26Danny L DearenSELL799949.46
2023-04-20Danny L DearenSELL200160.01

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Axonics Modulation Technologies Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.5280.330+60%0.430+23%0.485+9%0.481+10%
Book Value Per Share--12.50011.962+4%9.905+26%7.687+63%5.957+110%
Current Ratio--10.72611.343-5%9.262+16%11.329-5%11.426-6%
Debt To Asset Ratio--0.1140.094+22%0.133-14%0.151-24%0.394-71%
Debt To Equity Ratio--0.1290.091+41%0.154-16%0.180-28%0.166-22%
Dividend Per Share----0%-0%-0%-0%
Eps--0.1290.025+407%-0.293+327%-0.264+305%-0.234+282%
Free Cash Flow Per Share--0.085-0.027+132%0.005+1686%-0.221+361%-0.203+339%
Free Cash Flow To Equity Per Share--0.096-0.044+146%0.661-85%0.324-70%0.353-73%
Gross Profit Margin---7.381-1.461-80%-14.040+90%-1.834-75%-1.158-84%
Intrinsic Value_10Y_max--33.980--------
Intrinsic Value_10Y_min--28.072--------
Intrinsic Value_1Y_max--0.190--------
Intrinsic Value_1Y_min--0.185--------
Intrinsic Value_3Y_max--3.022--------
Intrinsic Value_3Y_min--2.836--------
Intrinsic Value_5Y_max--8.807--------
Intrinsic Value_5Y_min--7.964--------
Market Cap3390195998.000+6%3173941582.0002848284873.000+11%3216274404.000-1%2552822176.800+24%1993350188.846+59%
Net Profit Margin--0.060-0.088+247%-0.251+518%-2.602+4443%-1682.297+2808236%
Operating Margin--0.0420.196-79%-0.182+534%-2.467+5990%-1645.607+3929184%
Operating Ratio--0.9581.765-46%1.188-19%3.738-74%1685.193-100%
Pb Ratio5.317+6%4.9784.668+7%6.406-22%7.704-35%6.133-19%
Pe Ratio128.924+6%120.70197.870+23%268.697-55%52.658+129%39.740+204%
Price Per Share66.470+6%62.23055.845+11%63.060-1%50.052+24%39.083+59%
Price To Free Cash Flow Ratio196.056+6%183.550-56.761+131%-43.527+124%-49.570+127%-38.909+121%
Price To Total Gains Ratio125.824+6%117.79812.678+829%-23.408+120%-99.120+184%-94.218+180%
Quick Ratio--14.02014.003+0%8.559+64%11.415+23%11.896+18%
Return On Assets--0.009-0.003+128%-0.027+400%-0.049+632%-0.072+884%
Return On Equity--0.0100.000+5748%-0.032+406%-0.060+679%-0.058+662%
Total Gains Per Share--0.5280.330+60%0.430+23%0.485+9%0.481+10%
Usd Book Value--637564000.000610123000.000+4%505203750.000+26%392041600.000+63%303816792.308+110%
Usd Book Value Change Per Share--0.5280.330+60%0.430+23%0.485+9%0.481+10%
Usd Book Value Per Share--12.50011.962+4%9.905+26%7.687+63%5.957+110%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.1290.025+407%-0.293+327%-0.264+305%-0.234+282%
Usd Free Cash Flow--4323000.000-1391500.000+132%242000.000+1686%-11281900.000+361%-10337518.731+339%
Usd Free Cash Flow Per Share--0.085-0.027+132%0.005+1686%-0.221+361%-0.203+339%
Usd Free Cash Flow To Equity Per Share--0.096-0.044+146%0.661-85%0.324-70%0.353-73%
Usd Market Cap3390195998.000+6%3173941582.0002848284873.000+11%3216274404.000-1%2552822176.800+24%1993350188.846+59%
Usd Price Per Share66.470+6%62.23055.845+11%63.060-1%50.052+24%39.083+59%
Usd Profit--6574000.000-1522000.000+123%-14924500.000+327%-14035150.000+313%-12409225.308+289%
Usd Revenue--109735000.00074047250.000+48%68425500.000+60%43776800.000+151%33706816.846+226%
Usd Total Gains Per Share--0.5280.330+60%0.430+23%0.485+9%0.481+10%
 EOD+4 -4MRQTTM+25 -9YOY+28 -65Y+27 -710Y+27 -7

4.2. Fundamental Score

Let's check the fundamental score of Axonics Modulation Technologies Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15128.924
Price to Book Ratio (EOD)Between0-15.317
Net Profit Margin (MRQ)Greater than00.060
Operating Margin (MRQ)Greater than00.042
Quick Ratio (MRQ)Greater than114.020
Current Ratio (MRQ)Greater than110.726
Debt to Asset Ratio (MRQ)Less than10.114
Debt to Equity Ratio (MRQ)Less than10.129
Return on Equity (MRQ)Greater than0.150.010
Return on Assets (MRQ)Greater than0.050.009
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Axonics Modulation Technologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.410
Ma 20Greater thanMa 5067.894
Ma 50Greater thanMa 10067.953
Ma 100Greater thanMa 20065.648
OpenGreater thanClose66.750
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets719,923
Total Liabilities82,359
Total Stockholder Equity637,564
 As reported
Total Liabilities 82,359
Total Stockholder Equity+ 637,564
Total Assets = 719,923

Assets

Total Assets719,923
Total Current Assets491,422
Long-term Assets228,501
Total Current Assets
Cash And Cash Equivalents 104,811
Short-term Investments 240,149
Net Receivables 57,243
Inventory 79,940
Other Current Assets 9,279
Total Current Assets  (as reported)491,422
Total Current Assets  (calculated)491,422
+/-0
Long-term Assets
Property Plant Equipment 33,260
Goodwill 99,417
Intangible Assets 81,375
Other Assets 0
Long-term Assets  (as reported)228,501
Long-term Assets  (calculated)214,052
+/- 14,449

Liabilities & Shareholders' Equity

Total Current Liabilities45,816
Long-term Liabilities36,543
Total Stockholder Equity637,564
Total Current Liabilities
Short-term Debt 1,777
Accounts payable 18,452
Other Current Liabilities 25,587
Total Current Liabilities  (as reported)45,816
Total Current Liabilities  (calculated)45,816
+/-0
Long-term Liabilities
Capital Lease Obligations 27,617
Long-term Liabilities  (as reported)36,543
Long-term Liabilities  (calculated)27,617
+/- 8,926
Total Stockholder Equity
Common Stock5
Retained Earnings -380,352
Accumulated Other Comprehensive Income -15,867
Other Stockholders Equity 1,033,778
Total Stockholder Equity (as reported)637,564
Total Stockholder Equity (calculated)637,564
+/-0
Other
Capital Stock5
Cash and Short Term Investments 344,960
Common Stock Shares Outstanding 49,403
Liabilities and Stockholders Equity 719,923
Net Debt -77,194
Net Invested Capital 637,564
Net Working Capital 445,606
Property Plant and Equipment Gross 21,625
Short Long Term Debt Total 27,617



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
0
0
29,412
29,412
45,800
45,800
42,319
171,906
159,427
146,452
126,044
219,822
217,379
348,736
347,671
342,206
444,970
565,512
561,305
547,945
525,571
514,088
632,278
659,353
665,691
648,985
660,747
719,923
719,923660,747648,985665,691659,353632,278514,088525,571547,945561,305565,512444,970342,206347,671348,736217,379219,822126,044146,452159,427171,90642,31945,80045,80029,41229,41200
   > Total Current Assets 
8,209
0
26,919
26,919
24,398
43,430
35,335
165,340
152,799
138,016
117,824
211,680
204,065
335,505
334,458
327,946
228,372
332,183
330,229
321,317
307,433
313,127
449,361
465,075
469,671
455,396
475,385
491,422
491,422475,385455,396469,671465,075449,361313,127307,433321,317330,229332,183228,372327,946334,458335,505204,065211,680117,824138,016152,799165,34035,33543,43024,39826,91926,91908,209
       Cash And Cash Equivalents 
-8,209
0
24,398
24,398
-24,398
24,729
20,148
98,306
89,334
82,680
76,231
171,082
159,820
287,679
269,280
241,181
130,962
231,140
228,797
220,878
213,180
203,236
241,331
238,846
240,105
-2,968
147,323
104,811
104,811147,323-2,968240,105238,846241,331203,236213,180220,878228,797231,140130,962241,181269,280287,679159,820171,08276,23182,68089,33498,30620,14824,729-24,39824,39824,3980-8,209
       Short-term Investments 
16,417
0
0
0
48,796
15,152
11,069
59,218
54,819
43,001
25,311
12,592
12,592
0
0
0
0
0
0
0
0
9,998
108,682
118,365
116,957
186,173
197,393
240,149
240,149197,393186,173116,957118,365108,6829,9980000000012,59212,59225,31143,00154,81959,21811,06915,15248,79600016,417
       Net Receivables 
0
0
500
500
514
14
219
427
804
1,286
954
7,879
20,770
14,115
17,650
18,270
21,509
25,646
26,641
29,044
27,425
36,115
36,960
44,817
40,200
47,436
48,944
57,243
57,24348,94447,43640,20044,81736,96036,11527,42529,04426,64125,64621,50918,27017,65014,11520,7707,8799541,2868044272191451450050000
       Other Current Assets 
0
0
0
980
0
1,621
1,751
3,716
2,778
3,074
2,625
4,468
4,245
3,573
3,220
5,435
4,658
5,006
4,433
6,449
4,952
5,366
4,561
7,282
6,342
6,361
6,816
9,279
9,2796,8166,3616,3427,2824,5615,3664,9526,4494,4335,0064,6585,4353,2203,5734,2454,4682,6253,0742,7783,7161,7511,6210980000
   > Long-term Assets 
0
0
0
2,493
0
2,370
6,984
6,566
6,628
8,436
8,220
8,142
13,314
13,231
13,213
14,260
216,598
233,329
231,076
226,628
218,138
200,961
182,917
194,278
196,020
101,697
185,362
228,501
228,501185,362101,697196,020194,278182,917200,961218,138226,628231,076233,329216,59814,26013,21313,23113,3148,1428,2208,4366,6286,5666,9842,37002,493000
       Property Plant Equipment 
0
0
1,530
1,530
1,459
1,459
2,817
2,784
2,887
3,000
2,952
3,047
5,406
5,562
5,792
6,328
6,048
5,958
6,168
6,915
6,907
7,228
7,103
6,798
7,017
6,349
6,556
33,260
33,2606,5566,3497,0176,7987,1037,2286,9076,9156,1685,9586,0486,3285,7925,5625,4063,0472,9523,0002,8872,7842,8171,4591,4591,5301,53000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
87,382
106,631
109,565
105,510
102,558
94,852
86,942
94,414
96,581
98,880
95,287
99,417
99,41795,28798,88096,58194,41486,94294,852102,558105,510109,565106,63187,3820000000000000000
       Intangible Assets 
0
0
541
541
483
483
455
426
397
368
340
311
282
254
225
196
115,023
113,416
108,302
106,469
101,179
91,627
81,787
86,253
85,888
85,543
80,274
81,375
81,37580,27485,54385,88886,25381,78791,627101,179106,469108,302113,416115,02319622525428231134036839742645548348354154100
       Other Assets 
0
0
422
422
428
428
3,612
256
244
668
628
584
6,926
615
7,196
7,736
8,145
624
7,041
7,734
694
7,254
7,085
613
634
91,892
2,045
0
02,04591,8926346137,0857,2546947,7347,0416248,1457,7367,1966156,9265846286682442563,61242842842242200
> Total Liabilities 
0
0
2,540
64,766
14,024
96,151
100,131
28,631
28,093
32,039
33,856
36,819
44,903
50,840
53,773
54,836
114,816
61,247
71,215
65,507
62,139
76,362
82,760
89,214
89,085
33,283
50,127
82,359
82,35950,12733,28389,08589,21482,76076,36262,13965,50771,21561,247114,81654,83653,77350,84044,90336,81933,85632,03928,09328,631100,13196,15114,02464,7662,54000
   > Total Current Liabilities 
0
0
2,405
2,405
4,986
4,986
5,496
5,887
6,694
11,300
15,543
12,033
19,847
30,829
38,816
45,682
24,046
24,387
27,751
26,868
25,519
29,859
60,843
65,247
66,170
32,084
35,593
45,816
45,81635,59332,08466,17065,24760,84329,85925,51926,86827,75124,38724,04645,68238,81630,82919,84712,03315,54311,3006,6945,8875,4964,9864,9862,4052,40500
       Short-term Debt 
0
0
0
0
0
0
800
768
2,228
4,485
7,007
602
5,794
10,851
15,908
22,390
1,384
1,437
1,510
1,366
1,403
1,429
1,523
1,562
1,557
1,769
1,971
1,777
1,7771,9711,7691,5571,5621,5231,4291,4031,3661,5101,4371,38422,39015,90810,8515,7946027,0074,4852,228768800000000
       Short Long Term Debt 
0
0
0
0
0
0
800
768
1,705
3,897
6,382
0
5,000
10,000
15,000
21,110
22
30
109
0
0
0
0
32,600
0
0
0
0
000032,6000000109302221,11015,00010,0005,00006,3823,8971,705768800000000
       Accounts payable 
0
0
1,616
1,616
2,087
2,087
1,983
3,436
2,102
3,185
4,232
5,882
7,440
10,728
9,415
10,660
11,446
9,447
10,512
7,654
10,390
10,207
9,972
9,070
14,737
12,185
14,666
18,452
18,45214,66612,18514,7379,0709,97210,20710,3907,65410,5129,44711,44610,6609,41510,7287,4405,8824,2323,1852,1023,4361,9832,0872,0871,6161,61600
       Other Current Liabilities 
0
0
0
789
0
2,899
2,713
1,683
2,364
3,630
4,304
5,549
6,613
9,250
13,493
12,632
11,216
13,503
15,729
17,848
13,726
18,223
49,348
54,615
49,876
18,130
18,956
25,587
25,58718,95618,13049,87654,61549,34818,22313,72617,84815,72913,50311,21612,63213,4939,2506,6135,5494,3043,6302,3641,6832,7132,8990789000
   > Long-term Liabilities 
0
0
0
62,361
0
91,164
94,635
22,744
21,399
20,739
18,313
24,786
25,056
20,011
14,957
9,154
90,770
36,860
43,464
38,639
36,620
46,503
21,917
23,967
22,915
1,199
14,534
36,543
36,54314,5341,19922,91523,96721,91746,50336,62038,63943,46436,86090,7709,15414,95720,01125,05624,78618,31320,73921,39922,74494,63591,164062,361000
       Long term Debt Total 
0
0
0
0
0
0
0
22,744
17,923
16,000
13,740
20,336
15,571
0
0
0
75,171
89
0
0
0
0
0
0
0
0
0
0
00000000008975,17100015,57120,33613,74016,00017,92322,7440000000
       Other Liabilities 
0
0
135
135
53
53
0
0
0
0
0
0
0
0
0
0
6,750
28,290
35,312
29,587
27,934
38,182
13,957
16,412
0
0
13,658
0
013,6580016,41213,95738,18227,93429,58735,31228,2906,7500000000000535313513500
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,626
26,432
19,217
17,564
15,782
0
16,412
15,737
0
0
0
00015,73716,412015,78217,56419,21726,43220,62600000000000000000
> Total Stockholder Equity
9,069
0
-66,421
-66,421
26,872
-81,418
-88,878
143,275
131,334
114,413
92,188
183,003
172,476
297,896
293,898
287,370
330,154
504,265
490,090
482,438
463,432
437,726
549,518
570,139
576,606
-18,321
610,620
637,564
637,564610,620-18,321576,606570,139549,518437,726463,432482,438490,090504,265330,154287,370293,898297,896172,476183,00392,188114,413131,334143,275-88,878-81,41826,872-66,421-66,42109,069
   Retained Earnings -380,352-386,926-390,854-383,512-374,264-374,929-358,677-337,234-314,566-299,400-282,150-257,002-234,499-223,151-213,983-194,200-179,584-156,833-131,827-112,766-99,649-89,984-82,418-82,418-67,166-67,16600
   Accumulated Other Comprehensive Income -15,867-24,511-18,326-22,076-25,147-36,185-24,128-11,480-6,560-6,912-1,774-2,633-431-614-713-605-428-581-469-426-416-406-4060-403000
   Capital Surplus 
0
0
0
0
0
0
0
243,337
244,523
246,706
249,599
363,012
367,278
0
0
522,296
589,785
788,184
796,397
803,559
812,141
820,526
960,627
969,545
982,189
0
0
0
000982,189969,545960,627820,526812,141803,559796,397788,184589,785522,29600367,278363,012249,599246,706244,523243,3370000000
   Treasury Stock0000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue366,379
Cost of Revenue-100,889
Gross Profit265,490265,490
 
Operating Income (+$)
Gross Profit265,490
Operating Expense-270,202
Operating Income-4,712-4,712
 
Operating Expense (+$)
Research Development34,886
Selling General Administrative45,754
Selling And Marketing Expenses189,562
Operating Expense270,202270,202
 
Net Interest Income (+$)
Interest Income16,152
Interest Expense-624
Other Finance Cost-1,216
Net Interest Income16,744
 
Pretax Income (+$)
Operating Income-4,712
Net Interest Income16,744
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,744-680
EBIT - interestExpense = -5,336
-8,744
-5,464
Interest Expense624
Earnings Before Interest and Taxes (EBIT)-4,712-8,120
Earnings Before Interest and Taxes (EBITDA)8,675
 
After tax Income (+$)
Income Before Tax-8,744
Tax Provision--2,060
Net Income From Continuing Ops-11,997-6,684
Net Income-6,088
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses371,091
Total Other Income/Expenses Net-4,032-16,744
 

Technical Analysis of Axonics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Axonics. The general trend of Axonics is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Axonics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Axonics Modulation Technologies Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 66.68 < 67.58 < 69.67.

The bearish price targets are: 64.76 > 63.84 > 55.55.

Tweet this
Axonics Modulation Technologies Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Axonics Modulation Technologies Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Axonics Modulation Technologies Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Axonics Modulation Technologies Inc. The current macd is -0.35665244.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Axonics price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Axonics. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Axonics price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Axonics Modulation Technologies Inc Daily Moving Average Convergence/Divergence (MACD) ChartAxonics Modulation Technologies Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Axonics Modulation Technologies Inc. The current adx is 20.12.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Axonics shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Axonics Modulation Technologies Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Axonics Modulation Technologies Inc. The current sar is 66.27.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Axonics Modulation Technologies Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Axonics Modulation Technologies Inc. The current rsi is 30.41. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Axonics Modulation Technologies Inc Daily Relative Strength Index (RSI) ChartAxonics Modulation Technologies Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Axonics Modulation Technologies Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Axonics price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Axonics Modulation Technologies Inc Daily Stochastic Oscillator ChartAxonics Modulation Technologies Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Axonics Modulation Technologies Inc. The current cci is -131.68869786.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Axonics Modulation Technologies Inc Daily Commodity Channel Index (CCI) ChartAxonics Modulation Technologies Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Axonics Modulation Technologies Inc. The current cmo is -58.9135098.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Axonics Modulation Technologies Inc Daily Chande Momentum Oscillator (CMO) ChartAxonics Modulation Technologies Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Axonics Modulation Technologies Inc. The current willr is -97.17514124.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Axonics Modulation Technologies Inc Daily Williams %R ChartAxonics Modulation Technologies Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Axonics Modulation Technologies Inc.

Axonics Modulation Technologies Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Axonics Modulation Technologies Inc. The current atr is 0.42262344.

Axonics Modulation Technologies Inc Daily Average True Range (ATR) ChartAxonics Modulation Technologies Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Axonics Modulation Technologies Inc. The current obv is -9,005,619.

Axonics Modulation Technologies Inc Daily On-Balance Volume (OBV) ChartAxonics Modulation Technologies Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Axonics Modulation Technologies Inc. The current mfi is 14.48.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Axonics Modulation Technologies Inc Daily Money Flow Index (MFI) ChartAxonics Modulation Technologies Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Axonics Modulation Technologies Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Axonics Modulation Technologies Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Axonics Modulation Technologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.410
Ma 20Greater thanMa 5067.894
Ma 50Greater thanMa 10067.953
Ma 100Greater thanMa 20065.648
OpenGreater thanClose66.750
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Axonics with someone you think should read this too:
  • Are you bullish or bearish on Axonics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Axonics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Axonics Modulation Technologies Inc

I send you an email if I find something interesting about Axonics Modulation Technologies Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Axonics Modulation Technologies Inc.

Receive notifications about Axonics Modulation Technologies Inc in your mailbox!